Using a kind of novel linker technology, the startup is developing versions of incretin and non-incretin therapies that can ...

Strong manufacturing base a driving force behind overseas expansion, but industry leaders and analysts say hurdles remain.

EU Council and Parliament negotiators have reached a provisional "pharma package" deal to modernize medicine rules, speed ...